1. Home
  2. SLRX

as 04-02-2025 4:00pm EST

$
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.

Founded: N/A Country:
United States
United States
Employees: N/A City: HOUSTON
Market Cap: 2.1M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 379.2K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -5.79 EPS Growth: N/A
52 Week Low/High: $0.70 - $7.20 Next Earning Date: 03-24-2025
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

SLRX Daily Stock ML Predictions

Share on Social Networks: